Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)
Clinical trial NCT03929120 · COMPLETED
Trial details
- NCT number
- NCT03929120
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2021-07-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.